Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies

The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest over the last decades. In particular, the analysis of biomarkers in cancer patients within the pre- and post-therapeutic period is required to identify several types of cells, which carry a risk for a disease pr...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, Reni Kitte, Sarah Dluczek, Alexander Strauß, André-René Blaudszun, Tetyana Yevsa, Stephan Fricke, Uta Kossatz-Boehlert
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-08-01
Subjects:	cancer stem cells senescence targeted therapy CAR cells biomarkers precision therapy
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01280/full